Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
about
Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of ActionWithaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signalingNovel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and ExtractsReal-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodiesEffect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice.Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives.Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells.Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation.Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transitionNovel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasionExpression of pigment epithelium-derived factor is associated with a good prognosis and is correlated with epithelial-mesenchymal transition-related genes in infiltrating ductal breast carcinoma.Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers.Vimentin as a Marker of Early Differentiating, Highly Motile Corneal Epithelial Cells.Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives.Role of phytochemicals in the inhibition of epithelial-mesenchymal transition in cancer metastasis.Natural Withanolides in the Treatment of Chronic Diseases.Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.Withaferin A Induces Oxidative Stress-Mediated Apoptosis and DNA Damage in Oral Cancer Cells.Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model.Carnosol controls the human glioblastoma stemness features through the epithelial-mesenchymal transition modulation and the induction of cancer stem cell apoptosis.Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion.Upregulation of matrix metalloproteinase triggers transdifferentiation of retinal pigmented epithelial cells in Xenopus laevis: A Link between inflammatory response and regeneration.Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression.miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.HSPC159 promotes proliferation and metastasis by inducing epithelial-mesenchymal transition and activating the PI3K/Akt pathway in breast cancer.Withaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells
P2860
Q26766956-B6C30905-B5C1-4574-97D5-A01B2C6B2E8AQ27302812-762C13C1-8D1A-4F26-8E61-5790AD8AE2E6Q28554871-39BFEA12-29A2-4975-91C8-F7F352F9D8FFQ30661925-3A71A773-08A2-4EF8-8321-1BEBA3C429BDQ35282975-CD4DCEE6-50ED-4C7A-BC3F-901BCBA67C01Q35595569-89396A32-7000-4D24-B74F-E461ECC153D7Q35729592-A3C7AC16-93C2-4FA9-B0F8-704205CA40E5Q36347307-4E7E5A5E-5C16-446B-830A-67AB7D48BA49Q36414180-4EB05443-5C13-4386-B939-89BB821B5C65Q36451879-38010638-9164-4421-9928-8F98E9E29AD3Q36503117-71B7C7E8-C31F-44A0-8244-DE0C7BCB1073Q37107334-ABC74C8B-DAB4-46C0-A5C8-916EA5A55159Q38758617-4F01E3DB-1E48-489C-99E1-0501C2367656Q38764079-DBAC7B0F-1C0B-4D8D-960C-97DD28A519BCQ38845930-10042D21-E72D-4DD7-BF93-C5E7093FDD36Q38923272-E6BFAC5E-6119-4659-96F4-BCCD2F47AACCQ38965226-96D991F9-5657-473C-9F56-A5B2AD4935C6Q40389234-96348AB8-D1BA-4700-AA5B-ED47E02ADF46Q41313717-500BF0A9-C936-40ED-8E1C-131AC1B4ADE6Q42137006-5AE94900-F204-4D59-8E5C-713A7CC73A44Q47158074-93F61396-B9A1-4E0D-85BE-1B68AA9D9AB7Q47326534-45480A86-B1F4-4BA0-9ACE-1433A88DE68DQ48328292-642C6584-D399-4473-A0CA-2DFB20DDCCBCQ51736337-549F1AD9-4928-4572-B316-B6ABAF1E419AQ54231260-7FDC591C-047B-4F34-858C-ED13CFA3814FQ55518180-C44A772F-EE5D-40B8-8AFE-AE19C617C881Q57794595-8DBF51B1-A5E5-42B4-BB2C-644B5CE8DB91
P2860
Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Withaferin A inhibits experime ...... evel in vivo in breast tumors.
@ast
Withaferin A inhibits experime ...... evel in vivo in breast tumors.
@en
type
label
Withaferin A inhibits experime ...... evel in vivo in breast tumors.
@ast
Withaferin A inhibits experime ...... evel in vivo in breast tumors.
@en
prefLabel
Withaferin A inhibits experime ...... evel in vivo in breast tumors.
@ast
Withaferin A inhibits experime ...... evel in vivo in breast tumors.
@en
P2093
P2860
P356
P1476
Withaferin A inhibits experime ...... evel in vivo in breast tumors.
@en
P2093
Adam I Marcus
Eun-Ryeong Hahm
Joomin Lee
Shivendra V Singh
P2860
P304
P356
10.1002/MC.22110
P577
2013-11-30T00:00:00Z